INVEST Pitch Perfect winner spotlight: Pleiogenix eyes road ahead for liver disease drug August 3, 2020 Auto Bot BioPharma, biopharma nl, California, invest 2020 virtual, nonalcoholic steatohepatitis 0 The company is hoping to close its seed funding round in the next six months and aims to be in a position to seek regulatory approval for its lead asset, PLX888, in acute alcoholic hepatitis in 2023.